James E. Crowe, MD

James E. Crowe, MD

Professor of Pediatrics and Pathology, Microbiology and Immunology
Pediatric Infectious Diseases
Director
Vanderbilt Vaccine Center
Ann Scott Carell Chair
Department of Pediatrics
Medical Center North
1161 21st Avenue South
Room / Suite
D-7235
Nashville
Tennessee
37232-2585
Phone
(615) 343-8064

Specialty
Infectious Diseases, Pediatric
M.D.
University of North Carolina, 1987
Residency
Residency in Pediatrics-University of North Carolina Chapel Hill, NC
Fellowships
Medical Staff Fellow in Virology-National Institutes of Health, Bethesda, MD
Clinical Fellowship, Pediatric Infectious Diseases-Vanderbilt University Medical Center, Nashville, TN

Clinical Interests

Emerging viral infections

Research Information

Dr. Crowe is Director of the Vanderbilt Vaccine Center and the Ann Scott Carell Professor of Pediatrics, Pathology, Microbiology and Immunology. His laboratory studies the human immune response to infection for a wide variety of major human pathogens, including many emerging infections. He is the Director of the HUMAN IMMUNOME PROJECT, an ambitious effort to identify the sequence of all transcripts for human adaptive immune receptors. He is an elected member of the National Academy of Medicine, National Academy of Inventors, and other major professional organizations. His work has been recognized by a number of international awards, including the Judson Daland Prize of the American Philosophical Society, the Oswald Avery Award of the IDSA, and the Korsmeyer Award of the American Society for Clinical Investigation. This research group uses a very broad array of techniques including molecular and cellular biology, state-of-the-art imaging and flow cytometry, bioinformatics, and bioengineering approaches to attack scientific problems at the forefront of immunity research. The group has been recognized widely as a leader in antibody sciences, for instance as the Best Academic Research Team, 11th Annual Vaccine Industry Excellence Awards, World Vaccine Congress, recipient of the 2019 Merck Future Insight Prize, and large-scale research grants and contracts from NIH and DoD, including the DARPA Pandemic Prevention Program (P3).

>> View Publications on PubMed